Wonyoung Choi

11PUBLICATIONS
65CO-AUTHORS
South-East Asian languages (excl. Indonesian)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 07, 2026
Agreement, Compliance, and Practice Change of the Korean Practice Guidelines for Gastric Cancer 2022: A Nationwide Multidisciplinary Survey.

|Apr 20, 2026
Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma.

|Oct 29, 2025
Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma.

Wonyoung Choi, Woojin Ham, Jeong Hwan Park

|Jan 17, 2025
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

In-Ho Kim, Seung Joo Kang, Wonyoung Choi

|Oct 07, 2024
Reply: Comment on The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences.

In-Ho Kim, Wonyoung Choi, Hye Sook Han

|Sep 19, 2024
Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma.

Hyondeog Kim, Wonyeop Lee, Youngwook Kim

Pageof 2

Frequent Collaborators

3 joint publications

Bang Wool Eom

3 joint publications

In-Ho Kim

3 joint publications

Hye Sook Han

3 joint publications

Sang Myung Woo